SYDNEY--(BUSINESS WIRE)--Omniscient Neurotechnology (“o8t™”), a pioneering brain mapping technology company, today announced the completion of an AUD 40 million Series B financing round. The funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback